Search Results

By SYED A. ABUTALIB, MD, AND MATTHEW J. PIANKO, MD  / February 2026  / ASH 2025

ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma

“Dripping water hollows out stone, not through force but through persistence.” – Ovid The 2025 American Society of Hematology (ASH) Annual Meeting & Exposition delivered multiple practice-changing datasets surrounding T-cell–redirecting therapies in relapsed or refractory multiple myeloma....